Salvia BioElectronics (Series B)
Funding Details
Awarder
RSS - tech.eu
Date Award
May 27, 2025
Vertical
Healthtech
Funding URL
View Funding Page
Funding Amount
$60,000,000
Company Info
Traction
Currently conducting the RECLAIM clinical trial, a multi-center, double-blind, sham-controlled study in Europe and Australia, with U.S. trials planned next.
Founders
Hubert Martens
Market
Chronic migraine treatment
Location
Eindhoven, Netherlands
Coinvestors
Innovation Industries, Invest-NL, EIC Fund, Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant Development Agency (BOM), Thuja Capital
Company Description

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Healthtech DealsView Funding Announcement